Monthly cost, self-pay or generic price (reviewed September 2026)
From cheapest to most expensive — before insurance. List price is shown separately where it differs from the self-pay range.
The landscape changed fast. Oral semaglutide (Wegovy pill), approved in late 2025, is priced by dose at $149–$299/month — making a GLP-1 accessible to far more people. Generic phentermine/topiramate costs as little as $30/month.
Insurance and savings programs
List prices are rarely what people pay. Two things commonly reduce costs significantly:
- Manufacturer savings cards — Eli Lilly's LillyDirect and Novo Nordisk's NovoCare can bring monthly costs down to as little as $25 for eligible patients on commercial insurance
- Insurance — coverage is inconsistent and varies by plan, employer, and country. Some plans cover GLP-1s for diabetes but not weight loss
- Medicare Part D — Foundayo (orforglipron) coverage expected from July 2026 at approximately $50/month
Cost Finder
What options fit your monthly budget?
List prices — actual costs vary. Prescription drugs may cost less with insurance or manufacturer savings programs.
Devices, procedures and surgery are one-time costs rather than a monthly price, so they aren't in the slider above — see devices and procedures and the full treatment landscape.
Five ways to reduce what you pay
Get the manufacturer savings card
Both Novo Nordisk (NovoCare) and Eli Lilly (LillyDirect) offer savings programmes. With commercial insurance, your copay may be reduced to as little as $25/month. These cards are free and can be applied at the pharmacy.
Ask about the oral pill version
For semaglutide, the oral pill (Wegovy pill, $149–$299/mo by dose) produced weight loss in a similar range to the injection ($1,349/month at list price) in its own trial, at a fraction of the injection's list price.
Compare pharmacy prices
Prices vary significantly between pharmacies. Use GoodRx or similar tools to compare pricing. Mail-order pharmacies and big-box retailers (Costco, Sam's Club) sometimes offer lower prices.
More ways to reduce what you pay
Check if you qualify for patient assistance
Both manufacturers offer patient assistance programmes for people without insurance or with financial hardship. These can provide medication at no cost for qualifying individuals.
Work your insurance
If your plan denies coverage, ask your doctor about prior authorisation or step therapy. Some plans cover GLP-1s for diabetes but not weight loss — your doctor may be able to document medical necessity.
If cost is a hard barrier right now
If medication is not affordable right now, that does not mean your options are limited. Clinical data supports several non-medication approaches.
Structured diet (caloric deficit)
About 5–8% weight loss on average
Diet + exercise combined
About 7–10% weight loss on average
Alli (orlistat OTC)
About 5–6% weight loss, $40–$60/mo, no prescription
Evidence-rated supplements
Modest (1–3 kg), $10–50/month
Related questions
Other options and their costs
Written and maintained by one person · Built with agentic AI tools · Every number checked against the cited trial · Not medical advice
Pricing data and manufacturer programs
Costs listed are based on the pricing recorded in this site's drug data, checked 10 September 2026. Prices may vary by region, pharmacy, insurance, and change over time. Manufacturer savings program eligibility is income-based and subject to change. Always verify current pricing with your pharmacy or doctor.
- NovoCare — Wegovy savings and self-pay pricing — Novo Nordisk, checked 10 September 2026 View source ↗
- Zepbound coverage and savings — Eli Lilly, checked 10 September 2026 View source ↗
Next step most people take
Built with agentic AI tools and not a substitute for medical advice
Last reviewed: